Posted inGenetics
HBV’s Ability to Infect Human Liver Cells Thwarted by Potential Anticancer Drug
Atomic force microscopy images show hepatitis B DNA in its natural state (left) and a zoomed-in look at how it…
Posted inGenetics
Incyte, Genesis Therapeutics Partner on AI-Based Small Molecule Collaboration
Evan Feinberg, PhD, founder and CEO of Genesis Therapeutics Incyte will partner with Genesis Therapeutics to research, discover, and develop…
Posted inGenetics
Atrandi Raises $25M to Develop New Products Based on Semi-Permeable Capsule Tech
Atrandi Biosciences has raised $25 million in a Series A funding round led by Lux Capital, with participation from Vsquared…
Posted inGenetics
Native Read Sequencing for Methylation Profiling in Cancer Diagnostics
Panelists:Broadcast Date: Tuesday, March 18, 2025Time: 8:00 am PT, 11:00 am ET, 16:00 CETMethylation analysis holds significant promise for clinical…
Posted inGenetics
Harnessing Single-Cell RNA Sequencing to Study Retinal Ganglion Cell Regeneration in Optic Neuropathies
Broadcast Date: Tuesday, March 11, 2025Time: 8:00 am PT, 11:00 am ET, 16:00 CETSingle-cell RNA sequencing has established itself as…
Posted inGenetics
U.K. Feels Bullish on Commercial Advanced Therapy Manufacturing
The U.K.’s advanced therapy sector is increasing its capability to manufacture at the commercial scale. That’s according to Alice Brown,…
Posted inGenetics
Shaking Up Biosensors
Producing the best biotherapeutics depends increasingly on the use of sensors to track the process. One way to do that…
Posted inGenetics
Fed-Batch Data Inadequate for Continuous Cultivation in Certain Systems
Continuous processing can get products to market about 12 months faster than batch processing, according to a 2022 paper by…
Posted inGenetics
Innovative Tech is Attractive, but Expertise and Flexibility Win Contracts
Biopharmaceutical developers are attracted by innovative, “name” bioprocessing technologies, but contract manufacturers will always need to have expertise and flexibility…
Posted inGenetics
Arc Institute’s AI Model Evo 2 Designs the Genetic Code Across All Domains of Life
“Today, we can for all practical purposes read, write, and edit any sequence of DNA, but we cannot compose it.…